đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This is a multicenter, double-blind, randomized, placebo-controlled study d...
Status
Terminated
Location
Northwell Health
Start Date
2015-12-30
Trial ID
NCT02545283
Treatments Being Tested
The primary objective for this study is to assess the safety and tolerabili...
Status
Completed
Location
USC Norris Cancer Center
Start Date
2016-03-09
Trial ID
NCT02670044
Treatments Being Tested
This is a open-label, multicenter, non-randomized, study to evaluate the sa...
Status
Terminated
Location
Mayo Clinic Arizona
Start Date
2015-12-23
Trial ID
NCT02624986
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of idasanutlin...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2018-07-10
Trial ID
NCT03566485
Treatments Being Tested
The objective of N²M² is the improvement of overall survival of patients wi...
Status
Completed
Location
CharitĂŠ Berlin, Neurosurgery
Start Date
2018-05-07
Trial ID
NCT03158389
Treatments Being Tested
This research looks at two conditions, Essential Thrombocythemia (ET) and P...
Status
Completed
Location
Georgetown University Medical Center
Start Date
2015-04
Trial ID
NCT02407080
This Phase Ib/II, open-label, multicenter, non-randomized, dose-escalation ...
Status
Terminated
Location
University of Colorado
Start Date
2017-06-15
Trial ID
NCT03135262
Treatments Being Tested
iSTAR is an open-label, multi-center, phase 1b study of oral XPO1 inhibitor...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-03
Trial ID
NCT05952687
Treatments Being Tested
This multi-center, open-label, pharmacokinetic study will evaluate the bioe...
Status
Completed
Location
University of Colorado
Start Date
2017-11-27
Trial ID
NCT03362723
Treatments Being Tested
The purpose of this single-center, open-label, non-randomized study is to a...
Status
Completed
Location
Magyar Honvedseg Egeszsegugyi Kozpont
Start Date
2016-09-08
Trial ID
NCT02828930
Treatments Being Tested